IGC Pharma
26 hedge funds and large institutions have $1.46M invested in IGC Pharma in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
38% less capital invested
Capital invested by funds: $2.37M → $1.46M (-$906K)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
26
Holding in Top 10
–
Calls
$38K
Puts
$22K
Top Buyers
| 1 | +$58.4K | |
| 2 | +$50.9K | |
| 3 | +$27.9K | |
| 4 |
BlackRock
New York
|
+$7K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.98K |
Top Sellers
| 1 | -$85K | |
| 2 | -$73K | |
| 3 | -$23K | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$16K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$15K |